Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes
暂无分享,去创建一个
I. Pichová | J. Hodek | I. Hirsch | T. Baumert | L. Chaperot | J. Fronek | B. Lubyová | J. Chlupac | J. Weber | S. Durand | Vaclav Janovec | P. Dostalik | Kamila Clarova | Tomáš Hofman